R&D Whole-genome sequencing in the UK and Europe, with Mark Robi... Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
Oncology ESMO 2024 – Today’s oncological roots are branching What could a tree possibly reveal about the European Society for Medical Oncology (ESMO)?
Oncology Sponsored Case Study: MGI and Alacris Theranostics As World Cancer Day approached this year, the increasing focus on precision oncology continued apace.
News UK study backs whole-genome screening for cancer care A major new study in the UK has shown that combining whole-genome sequencing (WGS) and real-world clinical data at a national scale can help deliver tailored, personalised
Partner Content Partner Content 6th Annual Next Generation Sequencing USA Congress 2 days, 350+ end users, 80+ case studies
Partner Content Partner Content Next Generation Sequencing Market worth $15000 million by 20... Next Generation Sequencing Market to achieve 20% CAGR
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.